Copper GHK+ Andlitsserum með Cycloastragenol | Heilsubarinn

Copper GHK+ Andlitsserum með Cycloastragenol

8.950 kr

Copper GHK+ Andlitsserum með Cycloastragenol

8.950 kr
Thumbnail for Copper GHK+ Andlitsserum með Cycloastragenol | Heilsubarinn Thumbnail for Copper GHK+ Andlitsserum með Cycloastragenol | Heilsubarinn
Copper GHK+ Andlitsserum með Cycloastragenol | Heilsubarinn
Copper GHK+ Andlitsserum með Cycloastragenol | Heilsubarinn

Copper GHK+ Andlitsserum með Cycloastragenol

8.950 kr
  • GHK-Cu Peptíð: Styrkir, sléttir og stuðlar að endurnýjun húðar
  • Cycloastragenol (útdráttur úr rót): Styður við enduruppbyggingu og vörn gegn UV-skemmdum
  • Bakuchiol: Jurtaaðlagað retínól-alternatíf án ertingar eða þurrks
  • Hýalúrónsýra: Djúp vökvun fyrir fyllri og unglegri húð
  • Curcumin C3 Reduct®, Vítamín C og E: Sterk andoxunarefni sem lýsa húðina og verja gegn umhverfisálagi
  • Nanoemulsion tækni: Bætir upptöku virkra efna fyrir hraðar og skilvirkar niðurstöður
  • Hormónalaus formúla: Örugg og áhrifarík fyrir daglega notkun hjá fólki á öllum aldri og af báðum kynjum

Frí sending yfir 15 þúsund krónur. Pantanir eru afgreiddar samdægurs ef pantað er fyrir kl. 13, annars daginn eftir (virka daga). Ekki er afgreitt um helgar. Þær eru afhentar með Dropp, á þann stað sem þú velur.

Örugg greiðslulausn með Saltpay eða Netgíró.

Auðveld skil með Dropp.
Nánari Lýsing

Ný kynslóð peptíðhúðvörur með nanoemulsion tækni
2025 Skincare Anarchy “Top Picks” Verðlaunahafi

Taktu húðumhirðuna upp á næsta stig með Copper GHK+ andlits seruminu með Cycloastragenol – hormónalausri, háþróaðri formúlu sem fer dýpra en hefðbundin serum.

Með klínískt rannsökuðum peptíðum, jurtum og andoxunarefnum veitir það sýnilega endurnýjun þar sem önnur serum ná ekki til.

Kjarninn í formúlunni er GHK-Cu, endurnýjandi koparpeptíð sem þekkt er fyrir að styrkja og slétta húðina. Með Cycloastragenol, hýalúrónsýru, bakuchiol, curcumin og nanoformuðum C og E vítamínum, hjálpar serumið til við að styðja kollagenmyndun, jafna húðlit og berjast gegn sýnilegum öldrunareinkennum – án ertingar.

Formúlan hentar bæði konum og körlum, og nanoemulsion tækni Quicksilver tryggir djúpa upptöku og hraðar niðurstöður. Nógu mild til daglegrar notkunar – nógu öflug til umbreytingar.

ÍTARLEGRI UPPLÝSINGAR

Berið tvö pump daglega á hreint andlit eða háls áður en rakakrem er notað.
Klappið létt eða nuddið varlega þar til serumið hefur alveg gengið inn í húðina.

  1. Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-88. doi: 10.1163/156856208784909435. PMID: 18644225. https://pubmed.ncbi.nlm.nih.gov/18644225/
  2. Cushman CJ, Ibrahim AF, Smith AD, Hernandez EJ, MacKay B, Zumwalt M. Local and Systemic Peptide Therapies for Soft Tissue Regeneration: A Narrative Review. Yale J Biol Med. 2024 Sep 30;97(3):399-413. doi: 10.59249/TKNM3388. PMID: 39351323; PMCID: PMC11426299 https://pmc.ncbi.nlm.nih.gov/articles/PMC11426299/
  3. Pickart L, Vasquez-Soltero JM, Margolina A. GHK and DNA: resetting the human genome to health. Biomed Res Int. 2014; 2014:151479. doi: 10.1155/2014/151479. Epub 2014 Sep 11. PMID: 25302294; PMCID: PMC4180391 https://pubmed.ncbi.nlm.nih.gov/25302294/
  4. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. doi: 10.1155/2015/648108. Epub 2015 Jul 7. PMID: 26236730; PMCID: PMC4508379.https://pubmed.ncbi.nlm.nih.gov/26236730/
  5. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9. doi: 10.1093/gerona/glu057. PMID: 24833586. https://pubmed.ncbi.nlm.nih.gov/24833586/
  6. Brunet A, Berger SL. Epigenetics of aging and aging-related disease. J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1(Suppl 1):S17-20. doi: 10.1093/gerona/glu042. PMID: 24833581; PMCID: PMC4022130. https://pubmed.ncbi.nlm.nih.gov/24833581/
  7. Kevei É, Hoppe T. Ubiquitin sets the timer: impacts on aging and longevity. Nat Struct Mol Biol. 2014 Apr;21(4):290-2. doi: 10.1038/nsmb.2806. PMID: 24699075. https://pubmed.ncbi.nlm.nih.gov/24699075/
  8. Chondrogianni N, Sakellari M, Lefaki M, Papaevgeniou N, Gonos ES. Proteasome activation delays aging in vitro and in vivo. Free Radic Biol Med. 2014 Jun;71:303-320. doi: 10.1016/j.freeradbiomed.2014.03.031. Epub 2014 Mar 27. PMID: 24681338. https://pubmed.ncbi.nlm.nih.gov/24681338/
  9. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018; 19(7):1987. https://doi.org/10.3390/ijms19071987
  10. Sensenbrenner, M., Jaros, G.G., Moonen, G. et al. Effect of conditioned media on nerve cell differentiation. Experientia 36, 660–662 (1980). https://doi.org/10.1007/BF01970123
  11. Lindner G, Grosse G, Halle W, Henklein P. Uber die Wirkung eines synthetischen Tripeptids auf in vitro kultiviertes Nervengewebe [The effect of a synthetic tripeptide nervous tissue cultured in vitro]. Z Mikrosk Anat Forsch. 1979;93(5):820-8. German. PMID: 317547. https://pubmed.ncbi.nlm.nih.gov/317547/
  12. Pollard JD, Quan S, Kang T, Koch RJ. Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts. Arch Facial Plast Surg. 2005 Jan-Feb;7(1):27-31. doi: 10.1001/archfaci.7.1.27. PMID: 15655171. https://pubmed.ncbi.nlm.nih.gov/15655171/
  13. Steiling H, Werner S. Fibroblast growth factors: key players in epithelial morphogenesis, repair and cytoprotection. Curr Opin Biotechnol. 2003 Oct;14(5):533-7. doi: 10.1016/j.copbio.2003.08.003. PMID: 14580585. https://pubmed.ncbi.nlm.nih.gov/14580585/
  14. Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer. 2000 Sep;7(3):165-97. doi: 10.1677/erc.0.0070165. PMID: 11021964.https://pubmed.ncbi.nlm.nih.gov/11021964/
  15. Pickart, L. (2008). The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition, 19(8), 969–988. https://doi.org/10.1163/156856208784909435
  16. Canapp SO Jr, Farese JP, Schultz GS, Gowda S, Ishak AM, Swaim SF, Vangilder J, Lee-Ambrose L, Martin FG. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Vet Surg. 2003 Nov-Dec;32(6):515-23. doi: 10.1111/j.1532-950x.2003.00515.x. PMID: 14648529.https://pubmed.ncbi.nlm.nih.gov/14648529/
  17. Kukowska M, Kukowska-Kaszuba M, Dzierzbicka K. In vitro studies of antimicrobial activity of Gly-His-Lys conjugates as potential and promising candidates for therapeutics in skin and tissue infections. Bioorg Med Chem Lett. 2015 Feb 1;25(3):542-6. doi: 10.1016/j.bmcl.2014.12.029. Epub 2014 Dec 16. PMID: 25556094. https://pubmed.ncbi.nlm.nih.gov/25556094/
  18. Pohunková H, Stehlík J, Váchal J, Cech O, Adam M. Morphological features of bone healing under the effect of collagen-graft-glycosaminoglycan copolymer supplemented with the tripeptide Gly-His-Lys. Biomaterials. 1996 Aug;17(16):1567-74. doi: 10.1016/0142-9612(95)00310-x. PMID: 8842360. https://pubmed.ncbi.nlm.nih.gov/8842360/
  19. Godet D, Marie PJ. Effects of the tripeptide glycyl-L-histidyl-L-lysine copper complex on osteoblastic cell spreading, attachment and phenotype. Cell Mol Biol (Noisy-le-grand). 1995 Dec;41(8):1081-91. PMID: 8747089. https://pubmed.ncbi.nlm.nih.gov/8747089/
  20. Campbell JD, McDonough JE, Zeskind JE, Hackett TL, Pechkovsky DV, Brandsma CA, Suzuki M, Gosselink JV, Liu G, Alekseyev YO, Xiao J, Zhang X, Hayashi S, Cooper JD, Timens W, Postma DS, Knight DA, Lenburg ME, Hogg JC, Spira A. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med. 2012 Aug 31;4(8):67. doi: 10.1186/gm367. PMID: 22937864; PMCID: PMC4064320. https://pubmed.ncbi.nlm.nih.gov/22937864/
  21. Zhang Q, Yan L, Lu J, Zhou X. Glycyl-L-histidyl-L-lysine-Cu2+ attenuates cigarette smoke-induced pulmonary emphysema and inflammation by reducing oxidative stress pathway. Front Mol Biosci. 2022 Jul 22;9:925700. doi: 10.3389/fmolb.2022.925700. PMID: 35936787; PMCID: PMC9354777. https://pubmed.ncbi.nlm.nih.gov/35936787/
  22. Sakuma S, Ishimura M, Yuba Y, Itoh Y, Fujimoto Y. The peptide glycyl-ʟ-histidyl-ʟ-lysine is an endogenous antioxidant in living organisms, possibly by diminishing hydroxyl and peroxyl radicals. Int J Physiol Pathophysiol Pharmacol. 2018 Jun 25;10(3):132-138. PMID: 30042814; PMCID: PMC6055086. https://pubmed.ncbi.nlm.nih.gov/30042814/
  23. Beretta G, Arlandini E, Artali R, Anton JM, Maffei Facino R. Acrolein sequestering ability of the endogenous tripeptide glycyl-histidyl-lysine (GHK): characterization of conjugation products by ESI-MSn and theoretical calculations. J Pharm Biomed Anal. 2008 Jul 15;47(3):596-602. doi: 10.1016/j.jpba.2008.02.012. Epub 2008 Mar 10. PMID: 18378108. https://pubmed.ncbi.nlm.nih.gov/18378108/
  24. Beretta G, Artali R, Regazzoni L, Panigati M, Facino RM. Glycyl-histidyl-lysine (GHK) is a quencher of alpha,beta-4-hydroxy-trans-2-nonenal: a comparison with carnosine. insights into the mechanism of reaction by electrospray ionization mass spectrometry, 1H NMR, and computational techniques. Chem Res Toxicol. 2007 Sep;20(9):1309-14. doi: 10.1021/tx700185s. Epub 2007 Aug 3. PMID: 17672515. https://pubmed.ncbi.nlm.nih.gov/17672515/
  25. Pickart L, Vasquez-Soltero JM, Margolina A. The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline. Brain Sci. 2017 Feb 15;7(2):20. doi: 10.3390/brainsci7020020. PMID: 28212278; PMCID: PMC5332963. https://pmc.ncbi.nlm.nih.gov/articles/PMC5332963/
  26. Zhang Q, Liu J, Deng MM, Tong R, Hou G. Relief of ovalbumin-induced airway remodeling by the glycyl-l-histidyl-l-lysine-Cu2+ tripeptide complex via activation of SIRT1 in airway epithelial cells. Biomed Pharmacother. 2023 Aug;164:114936. doi: 10.1016/j.biopha.2023.114936. Epub 2023 May 29. PMID: 37257226.https://pubmed.ncbi.nlm.nih.gov/37257226/
  27. Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxid Med Cell Longev. 2012;2012:324832. doi: 10.1155/2012/324832. Epub 2012 May 10. PMID: 22666519; PMCID: PMC3359723. https://pmc.ncbi.nlm.nih.gov/articles/PMC3359723/
  28. Dou Y, Lee A, Zhu L, Morton J, Ladiges W. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020 Mar 27;2(1):58-61. doi: 10.31491/apt.2020.03.014. PMID: 35083444; PMCID: PMC8789089. https://pmc.ncbi.nlm.nih.gov/articles/PMC8789089/
  29. Tucker M, Keely A, Park JY, Rosenfeld M, Wezeman J, Mangalindan R, Ratner D, Ladiges W. Intranasal GHK peptide enhances resilience to cognitive decline in aging mice. bioRxiv [Preprint]. 2023 Nov 17:2023.11.16.567423. doi: 10.1101/2023.11.16.567423. PMID: 38014118; PMCID: PMC10680828. https://pubmed.ncbi.nlm.nih.gov/38014118/
  30. Tucker M, Liao GY, Park JY, Rosenfeld M, Wezeman J, Mangalindan R, Ratner D, Darvas M, Ladiges W. Behavioral and neuropathological features of Alzheimer's disease are attenuated in 5xFAD mice treated with intranasal GHK peptide. bioRxiv [Preprint]. 2023 Nov 21:2023.11.20.567908. doi: 10.1101/2023.11.20.567908. PMID: 38045355; PMCID: PMC10690187. https://pubmed.ncbi.nlm.nih.gov/38045355/
  31. Craig E. Thomas. The influence of medium components on Cu2+-dependent oxidation of low-density lipoproteins and its sensitivity to superoxide dismutase, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, Volume 1128, Issue 1, 1992, Pages 50-57. ISSN 0005-2760. https://doi.org/10.1016/0005-2760(92)90256-U.
  32. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. J Heinrich, L Balleisen, H Schulte, G Assmann, and J van de LooAuthor Info & Affiliations. Arteriosclerosis and Thrombosis: A Journal of Vascular Biology Volume 14, Number 1. https://doi.org/10.1161/01.ATV.14.1.54
  33. A.J. Lee, W.C.S. Smith, G.D.O. Lowe, H. Tunstall-Pedoe. Plasma fibrinogen and coronary risk factors: The Scottish heart health study, Journal of Clinical Epidemiology, Volume 43, Issue 9, 1990, Pages 913-919, ISSN 0895-4356. https://doi.org/10.1016/0895-4356(90)90075-Z
  34. Carty CL, Heagerty P, Heckbert SR, Jarvik GP, Lange LA, Cushman M, Tracy RP, Reiner AP. Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study. Ann Hum Genet. 2010 Jan;74(1):1-10. doi: 10.1111/j.1469-1809.2009.00551.x. PMID: 20059469; PMCID: PMC2946374.https://pubmed.ncbi.nlm.nih.gov/20059469/
  35. Schlesinger DH, Pickart L, Thaler MM. Growth-modulating serum tripeptide is glycyl-histidyl-lysine. Experientia. 1977 Mar 15;33(3):324-5. doi: 10.1007/BF02002806. PMID: 858356. https://pubmed.ncbi.nlm.nih.gov/858356/
  36. Wang X, Liu B, Xu Q, Sun H, Shi M, Wang D, Guo M, Yu J, Zhao C, Feng B. GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis. Wound Repair Regen. 2017 Apr;25(2):270-278. doi: 10.1111/wrr.12520. Epub 2017 Apr 27. PMID: 28370978. https://pubmed.ncbi.nlm.nih.gov/28370978/


© 2026 Heilsubarinn ehf. Allur réttur áskilinn.